Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Using Rapid Cycle Randomized Controlled Trials to Optimize the Influenza Clinical Decision Support Tool

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03415425
Recruitment Status : Recruiting
First Posted : January 30, 2018
Last Update Posted : October 3, 2019
Sponsor:
Information provided by (Responsible Party):
NYU Langone Health

Brief Summary:
The proposed study aims to examine several iterations of the Influenza Best Practice Alert at NYU Langone Health. The goal is to increase ordering of the influenza vaccine through the alert.

Condition or disease Intervention/treatment Phase
Clinical Decision Support Other: Current Version of the Influenza Alert Other: Alternate Modifications of the Influenza Alert Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 4000 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Using Rapid Cycle Randomized Controlled Trials to Optimize the Influenza Clinical Decision Support Tool
Actual Study Start Date : January 16, 2018
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : December 31, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Flu Flu Shot

Arm Intervention/treatment
Active Comparator: Usual Care
The current version of the alert will fire for this arm of the study.
Other: Current Version of the Influenza Alert
Intervention includes the current version of the Influenza Alert that fires in the electronic medical record if the patient has not received the flu vaccination, as part of usual care.

Active Comparator: Alert Iteration
A modified version of the alert will fire for this arm of the study.
Other: Alternate Modifications of the Influenza Alert
Intervention includes various iterations of the Influenza Alert that fires in the electronic medical record if the patient has not received the flu vaccination.




Primary Outcome Measures :
  1. Alert Cancelation Rate [ Time Frame: 2 months. ]
    Number of times alert fires in medical record within 2 Month period


Secondary Outcome Measures :
  1. Vaccination Rate at Discharge [ Time Frame: 2 months ]
    Number of vaccinations recorded in EMR within 2 Month period



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   3 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All NYU Langone Health inpatients eligible for the Influenza clinical decision support tool

Exclusion Criteria:

  • N/A

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03415425


Contacts
Layout table for location contacts
Contact: Ashley Bagheri, MS 6465012560 ashley.bagheri@nyumc.org

Locations
Layout table for location information
United States, New York
New York University School of Medicine Recruiting
New York, New York, United States, 10016
Contact: Masha Kuznetsova    646-501-2919    Masha.Kuznetsova@nyumc.org   
Principal Investigator: Leora Horwitz, MD, MHS         
Sponsors and Collaborators
NYU Langone Health
Investigators
Layout table for investigator information
Principal Investigator: Leora Horwitz, MD, MHS NYU Langone Health

Layout table for additonal information
Responsible Party: NYU Langone Health
ClinicalTrials.gov Identifier: NCT03415425    
Other Study ID Numbers: RCT CDS
First Posted: January 30, 2018    Key Record Dates
Last Update Posted: October 3, 2019
Last Verified: October 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No